ClinicalTrials.gg
Status unknownNCT03291678Updated Sep 26, 2017

Impact of Percutaneous Laparoscopic Assisted Internal Ring Ligation During Lap Orchiopexy

An interventional study of new laparoscopic orchiopexy and classic laparoscopic orchiopexy in Congenital Disorders, sponsored by Ahmed Hamdy Rateb. Status unknown. Open to male participants aged 6 Months to 2 Years. Per ClinicalTrials.gov, last updated 2017-09-26.

Sponsored by Ahmed Hamdy Rateb · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
6 Months to 2 Years
Sex
Male
01

Study summary

Impact of percutaneous internal ring ligation during laparoscopic orchiopexy in decreasing incidence of congenital hernia

Read the detailed description

Cryptorchidism is the most common genitourinary anomaly in male children. Its incidence can reach 3% in full term neonates, rising to 30% in premature boys . The treatment of the crypt orchid testicle is justified by the increased risk of infertility and malignancy, as well as an associated inguinal hernia and the risk of trauma to the ectopic testicle against the pubis. Furthermore, the psychological stigma of a missing testis for the patient, as well as the parents' anxiety is also factors that justify this type of treatment .

About 20% of crypt orchid testicles are non palpable. The treatment of non-descended testicles is mandatory due to the increased risk of infertility, present in up to 40% of the patients, as compared to 6% of control groups, including malignancy, which reaches 20 times that of normal adults .

The treatment of the crypt orchid testis before 2 years of age is recommended, treatment is necessary not only for the risk of malignancy, but also for the satisfaction and improvement in the quality of the patient's life and parents´ concern for their children's health.

In relation to diagnosis, despite a sensitivity of 70-90% in the diagnosis of inguinal testes, ultrasonography is not useful in intra-abdominal cases . Although presenting a better quality, both computed tomography and nuclear magnetic resonance lack sufficient sensitivity and specificity to be considered as gold standard diagnostic tools . More recently, the magnetic angioresonance was introduced with sensibility of 96% and specificity of 100%, but it is still a new method, with high costs, also requiring general anesthesia in children .

In relation to the treatment, the use of gonadotrophin for un descended testes presents a success rate of definitive descent to the scrotum of 21 to 56%, with better results in bilateral cases . Surgical treatment via an inguinal incision is the main treatment option for palpable testicles, but can also be employed for the evaluation and treatment of non-palpable testis. In this situation, however, surgical exploration can often require large incisions and extensive dissections, especially in bilateral cases. This can be avoided using laparoscopic evaluation, with a sensitivity and specificity reaching more than 90%

02

Conditions studied

03

In context

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

110 studies on the registry are indexed under Congenital, Hereditary, and Neonatal Diseases and Abnormalities; 20 are open to participants now.

This study's planned enrollment of 60 is above the median of 41 across 30 interventional studies indexed under Congenital, Hereditary, and Neonatal Diseases and Abnormalities.

Browse Congenital, Hereditary, and Neonatal Diseases and Abnormalities studies →

Lead sponsor

This is the only study on the registry with Ahmed Hamdy Rateb as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 2 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age above six months

    1. SEX must be male
    2. Surgical approach is closure of internal ring via percutaneous technique after delivery of undescended testis

Exclusion criteria

  1. Age less than 3 months

    1. Patients with palpable undescended testis
    2. Any associated major congenital anomalies like cardiac anomalies
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    new laparoscopic orchiopexy

    this group will subjected to classic laparoscopic orchiopexy by delivery of abdominal undescended testis to subdartos pouch of scrotum with closure of internal ring

    Procedure: new laparoscopic orchiopexy

  • Active comparator
    classic laparoscopic orchoipexy

    this group will subjected to classic laparoscopic orchiopexy by delivery of abdominal undescended testis to subdartos pouch of scrotum

    Procedure: classic laparoscopic orchiopexy

Interventions

  • Procedurenew laparoscopic orchiopexy

    closure of the internal ring of the inguinal canal after descending of the testis to scrotum using needle percutaneous

  • Procedureclassic laparoscopic orchiopexy

    delivery of abdominal testis into scrotum without closure of the internal ring of the inguinal canal

06

What researchers measure

Primary outcomes

  1. decrease incidence of congenital hernia which associated with undescended testis

    patient follow up will be after 15 days and then after two months by examination of the operation site ,stitches , and hernial orifices to be sure of absence of congenital hernia

    Time frame: one year

Secondary outcomes

  1. The secondary outcome measure postoperative complication

    close observation of the patient depending on follow up the wound daily ,occurence of edema by observation, good feeding of the patient by mother

    Time frame: one week post operative

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Sep 2017; primary completion for Sep 2018, 11 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2017
First posted
Sep 25, 2017
StartEst.
Sep 25, 2017
Primary completionEst.
Sep 5, 2018
CompletionEst.
Sep 6, 2018
Last update
Sep 26, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 26, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03291678
Lead sponsor
Ahmed Hamdy Rateb
Collaborators
Assiut University
Responsible party
Ahmed Hamdy Rateb (resident physician of general surgery assuit university, Assiut University) — Sponsor-investigator
First posted
Sep 25, 2017
Start date
Sep 25, 2017 (estimated)
Primary completion
Sep 5, 2018 (estimated)
Completion
Sep 6, 2018 (estimated)
Last update
Sep 26, 2017

Study contacts

Ahmed mohammed soliaman, dr
Contact
ahmed.ali15@med.au.edu.eg
0201091672661
mohamed abdelkader osman, prof
Contact
osman@med.aun.edu.eg
0201090266780
gamal abdel hamid ahmed, prof
principal investigator · prof of general surgery assuit university

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion